Koya Medical confirms attendance at two major investor conferences to discuss its evidence-based vascular therapy pipeline with institutional stakeholders.
Koya Medical announced participation in two investor conferences, indicating normal corporate visibility activities with no material financial impact.
Koya Medical, a developer of vascular disease therapies, announced its participation in two upcoming investor conferences. The company will present at the Goldman Sachs Healthcare Private Company Conference and another event, aiming to increase visibility among institutional investors.
The company is engaging with the investment community to discuss its evidence-based therapies for vascular disease and increase corporate visibility.